Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a ... this approval strengthens JNJ's psychiatric drug portfolio. However, Spravato remains ...

Drug overdoses and overdose deaths appear to ... must continue full force,” Cloud said in an email. Narcan nasal spray can save someone who is overdosing on an opioid such as oxycodone, heroin ...

Data: San Diego County Medical Examiner's Office; Chart: Axios Visuals The big picture ... availability and affordability of naloxone, a nasal spray medication that reverses opioid overdoses ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal spray that may cause “adverse” effects. The NasoGel was recalled by the ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray as the first and only monotherapy for adults with major depressive ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...